Loading...
Avisa Diagnostics Inc.
AVBT.CN•CNQ
Healthcare
Medical - Devices
CA$0.04
CA$0.00(0.00%)

Over the last four quarters, Avisa Diagnostics Inc. achieved steady financial progress, growing revenue from $0.00 in Q3 2020 to $0.00 in Q2 2021. Gross profit stayed firm with margins at N/A in Q2 2021 versus N/A in Q3 2020. Operating income totaled -$794413.00 in Q2 2021, maintaining a N/A margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at -$4.53M. Net income dropped to -$4.60M, with EPS at -$0.14. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan